Elan Corporation PLC (ELN) Bets $1 Billion on Theravance, Inc. (THRX) Drugs; Move to Spurn Its Hostile Suitor?
5/13/2013 6:40:50 AM
More...
|
FDA Approves GlaxoSmithKline (GSK)/Theravance, Inc. (THRX) Drug for COPD Lung Disease
5/10/2013 10:45:28 AM
More...
|
Theravance, Inc. (THRX) Reports First Quarter 2013 Financial Results
4/26/2013 9:53:37 AM
More...
|
Theravance, Inc. (THRX) to Split Into Drug Development, Royalty Companies
4/26/2013 7:13:44 AM
More...
|
Theravance, Inc. (THRX) to Present at Investor Conferences in May 2013
4/24/2013 10:07:07 AM
More...
|
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) Announce Regulatory Submission for ANORO™ ELLIPTA™ (UMEC/VI) in Japan
4/22/2013 12:06:52 PM
More...
|
Theravance, Inc. (THRX) to Webcast 2013 Annual Meeting of Stockholders on April 24, 2013
4/22/2013 12:02:05 PM
More...
|
FDA Panel Backs Approval of GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Lung Drug
4/18/2013 7:14:14 AM
More...
|
Trading in Theravance, Inc. (THRX) Common Stock Halted
4/17/2013 10:51:18 AM
More...
|
Theravance, Inc. (THRX) to Report First Quarter 2013 Financial Results on April 25, 2013
4/12/2013 9:23:29 AM
More...
|
|